We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » CorePharma Satisfies FDA Batch Investigation Concerns
CorePharma Satisfies FDA Batch Investigation Concerns
June 4, 2013
Generic drugmaker CorePharma created a successful formula for quality control, prompting the FDA on May 3 to close out the company’s June 2010 warning letter.